Pediatric Nephrourology Division, Department of Pediatrics, National Institute of Science and Technology (INCT) of Molecular Medicine, School of Medicine, Federal University of Minas Gerais (UFMG), R. Engenheiro Amaro Lanari 389/501, Belo Horizonte, MG, 30310-580, Brazil.
Department of Statistics, UFMG, Belo Horizonte, Brazil.
Pediatr Nephrol. 2019 Feb;34(2):283-294. doi: 10.1007/s00467-018-4078-0. Epub 2018 Sep 8.
Posterior urethral valves (PUVs) are associated with severe consequences to the urinary tract and are a common cause of chronic kidney disease (CKD). The aim of this study was to develop clinical predictive model of CKD in a cohort of patients with PUVs.
In this retrospective cohort study, 173 patients with PUVs were systematically followed up at a single tertiary unit. The primary endpoint was CKD ≥ stage 3. Survival analyses were performed by Cox regression proportional hazard models with time-fixed and time-dependent covariables.
Mean follow-up time was 83 months (SD, 70 months). Sixty-five children (37.6%) developed CKD stage ≥ 3. After adjustment by the time-dependent Cox model, baseline creatinine, nadir creatinine, hypertension, and proteinuria remained as predictors of the endpoint. After adjustment by time-fixed model, three variables were predictors of CKD ≥ stage 3: baseline creatinine, nadir creatinine, and proteinuria. The prognostic risk score was divided into three categories: low-risk (69 children, 39.9%), medium-risk (45, 26%), and high-risk (59, 34.1%). The probability of CKD ≥ stage 3 at 10 years age was estimated as 6%, 40%, and 70% for patients assigned to the low-risk, medium-risk, and high-risk groups, respectively (P < 0.001). The main limitation was the preclusion of some relevant variables, especially bladder dysfunction, that might contribute to a more accurate prediction of renal outcome.
The model accurately predicts the risk of CKD in PUVs patients. This model could be clinically useful in applying timely intervention and in preventing the impairment of renal function.
后尿道瓣膜(PUV)与严重的尿路后果相关,是慢性肾脏病(CKD)的常见病因。本研究旨在为 PUV 患者队列建立 CKD 的临床预测模型。
在这项回顾性队列研究中,对单一三级单位的 173 名 PUV 患者进行系统随访。主要终点为 CKD≥3 期。采用时固定和时变协变量的 Cox 比例风险模型进行生存分析。
平均随访时间为 83 个月(标准差为 70 个月)。65 名儿童(37.6%)发展为 CKD 3 期以上。经时变 Cox 模型校正后,基线肌酐、最低肌酐、高血压和蛋白尿仍然是终点的预测因素。经时固定模型校正后,三个变量是 CKD≥3 期的预测因素:基线肌酐、最低肌酐和蛋白尿。预后风险评分分为三个类别:低危(69 名儿童,39.9%)、中危(45 名,26%)和高危(59 名,34.1%)。低危、中危和高危组患者 10 年时 CKD≥3 期的概率分别估计为 6%、40%和 70%(P<0.001)。主要限制是排除了一些可能有助于更准确预测肾脏结局的相关变量,尤其是膀胱功能障碍。
该模型能准确预测 PUV 患者发生 CKD 的风险。该模型可在临床上用于及时干预,并预防肾功能损害。